Cardiovascular disease mortality in patients with genetically verified familial hypercholesterolemia in Norway during 1992-2013. (Q39236327)

10 September 2017

title

Cardiovascular disease mortality in patients with genetically verified familial hypercholesterolemia in Norway during 1992-2013. (English)

1 reference

familial hypercholesterolemia

10 September 2017

0 references

cardiovascular disease

1 reference

based on heuristic

inferred from title

1 reference

1 reference

Marit B Veierød

0 references

Jannicke Igland

1 reference

10 September 2017

Kjetil Retterstøl

1 reference

10 September 2017

Kirsten B Holven

1 reference

10 September 2017

Liv Mundal

1 reference

10 September 2017

Leiv Ose

series ordinal

1 reference

10 September 2017

Trond P Leren

series ordinal

1 reference

10 September 2017

publication date

28 October 2016

1 reference

European Journal of Preventive Cardiology

10 September 2017

published in

1 reference

10 September 2017

1 reference

10 September 2017

1 reference

10 September 2017

page(s)

137-144

1 reference

Prevalence and management of familial hypercholesterolaemia in coronary patients: An analysis of EUROASPIRE IV, a study of the European Society of Cardiology

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F2047487316676135

Mortality among patients with familial hypercholesterolemia: a registry-based study in Norway, 1992-2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487316676135

Pregnancy outcomes in familial hypercholesterolemia: a registry-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487316676135

Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487316676135

Management of patients with familial hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487316676135

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487316676135

Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487316676135

Subjects with Molecularly Defined Familial Hypercholesterolemia or Familial Defective apoB-100 Are Not Being Adequately Treated

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487316676135

Data quality in the Causes of Death Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487316676135

Does quality control of death certificates in hospitals have an impact on cause of death statistics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487316676135

Diagnostic validity of fatal cerebral strokes and coronary deaths in mortality statistics: an autopsy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487316676135

Efficacy and safety of alirocumab in reducing lipids and cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F2047487316676135

21 January 2018

Identifiers

DOI

10.1177/2047487316676135

1 reference

10 September 2017

1 reference